Stockscreener 앱 받기
5.30
1.15%
0.06
시장 영업 전:
5.38
0.08
+1.51%
Atyr Pharma Inc 주식(ATYR)의 최신 뉴스
Traders Consider Averaging Down in aTyr Pharma Inc.Entry Alert Based on Volume Spikes Detected - metal.it
Promising Developments and Strong Financial Position Drive Buy Rating for aTyr Pharma - TipRanks
1 Small-Cap Biotech Stock Poised for a Breakout - AOL.com
Connect Biopharma Holdings Limited shares rise 1.93% intraday after aTyr Pharma announced Phase 3 EFZO-FIT™ study completion. - AInvest
3 Innovation Stocks With Parabolic Upside Potential - AOL.com
3 Innovation Stocks With Parabolic Upside Potential - The Motley Fool
aTyr Pharma Reports Q2 2025 Financial Results - TipRanks
Atyr Pharma: Q2 Earnings Snapshot - Stamford Advocate
aTyr Pharma Announces Second Quarter 2025 Results and Provides Corporate Update - GlobeNewswire
aTyr Pharma reports Q2 EPS (22c), consensus (18c) - TipRanks
Major Phase 3 Milestone: aTyr's Pulmonary Sarcoidosis Drug Shows Promise as 268-Patient Trial Wraps Up - Stock Titan
aTyr Pharma Inc put volume heavy and directionally bearish - TipRanks
aTyr Pharma stock awaits key Phase 3 trial results, Cantor Fitzgerald maintains Overweight rating - Investing.com Canada
aTyr Pharma stock rating reiterated by Cantor Fitzgerald ahead of trial data - Investing.com Canada
Is aTyr Pharma (NASDAQ:ATYR) In A Good Position To Invest In Growth? - Yahoo Finance
Should I hold or sell aTyr Pharma Inc. stock in 2025Free Trading Psychology Coaching - Jammu Links News
Is it the right time to buy aTyr Pharma Inc. stockOutstanding risk-reward balance - Jammu Links News
What drives aTyr Pharma Inc. stock priceDiscover stocks with explosive growth potential - Jammu Links News
What are the technical indicators suggesting about aTyr Pharma Inc.Invest confidently with professional market insights - Jammu Links News
What analysts say about aTyr Pharma Inc. stockAchieve exceptional returns with expert guidance - Jammu Links News
What makes aTyr Pharma Inc. stock price move sharplyDiscover high-impact stocks for your portfolio - Jammu Links News
How does aTyr Pharma Inc. generate profit in a changing economyMaximize your gains with expert trading tips - Jammu Links News
Is aTyr Pharma Inc. stock overvalued or undervaluedBuild a portfolio that withstands market volatility - Jammu Links News
What institutional investors are buying aTyr Pharma Inc. stockCapitalize on fast-moving stock opportunities - Jammu Links News
Is aTyr Pharma Inc. in Accumulation Phase NowExpert Verified Stock Trade Ideas Backed by Data - metal.it
Martin Shkreli Is Shorting This ‘Strong Buy’ Penny Stock. How Should You Play Shares Here? - Barchart.com
Price Channel Expanding on aTyr Pharma Inc.’s ChartReal Time Stock Movement Analysis Indicates Breakout - metal.it
Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), aTyr Pharma (ATYR) and HCA Healthcare (HCA) - The Globe and Mail
Price Consolidation Hints at Upcoming Move in aTyr Pharma Inc.Swing Trading Entry Signals Suggest Opportunity Zone - metal.it
Wyckoff Accumulation Phase Possible in aTyr Pharma Inc.Entry Plan for Oversold Reversal Stocks Released - metal.it
Will aTyr Pharma Inc. Recover After Recent DeclineMarket Momentum Signal Generator Shows Trends - metal.it
Published on: 2025-07-29 07:01:04 - beatles.ru
aTyr Pharma Inc. Breakout Confirmed by Volume MetricsWatchlist for Smart Swing Trading Updated - metal.it
aTyr Pharma Stock Faces Market Scrutiny Amid Financial Challenges - StocksToTrade
aTyr Pharma Inc. Company’s Quarterly Earnings Growth: What the Numbers SayMarket Entry and Exit Point Tips From Traders - metal.it
What is aTyr Pharma Inc. company’s growth strategyMaximize returns with data-driven strategies - Jammu Links News
What are aTyr Pharma Inc. company’s key revenue driversGet daily updates on the hottest stocks - Jammu Links News
0.24%
3.39%
자본화:
|
볼륨(24시간):